BRAINTEASER Final event – Tuesday 3rd June 2025 - @ENCALS 2025 Meeting   As the BRAINTEASER project nears its conclusion, its final conference will be held on 3 June 2025 in Turin, Italy, as an official satellite event of the ENCALS 2025...

As the BRAINTEASER project approaches its conclusion, its final conference will be held on 3 June 2025 in Turin, Italy, as an official satellite event of the ENCALS 2025 Meeting—the annual gathering of the European Network to Cure ALS. Hosted at...

Arianna Dagliati – Tenure-Track Assistant Professor - Università di Pavia - Department of Electrical, Computer and Biomedical Engineering Pietro Bosoni – Assistant Professor – Università di Pavia - Department of Electrical, Computer and Biomedical...

On 14 March, the BRAINTEASER event "Artificial Intelligence and the Environment: New Frontiers for Research and Treatment of Neurodegenerative Diseases" took place at Fondazione Mondino IRCCS in Pavia as part of the Brain Awareness Week. This...

Exploring AI and the environment in neurodegenerative disease research   “La Settimana del Cervello” – Brain Awareness Week – is an international initiative aimed at raising awareness about advancements in brain research, neurological and...

BRAINTEASER’s liaison activities are fostering synergies in brain research to maximise impact, with a particular focus on leveraging AI to improve the lives of people living with neurological conditions like Multiple Sclerosis (MS) and Amyotrophic...

Bringing Artificial Intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis 13 November 2024 from 16:00-17:50 CET at Brain Innovation Days, The EGG Brussels, Belgium Register for online participation!   Join...

As the BRAINTEASER project draws to a close, Natalia Allegretti, Senior Innovation Project Manager at ECHAlliance and leader of its dissemination and communication, sits down with Prof. Adriano Chiò, neurologist and head of the ALS Centre at the...

Exploitation is a crucial activity of BRAINTEASER as it connects the results of the project to their subsequent market commercialization, aiming at a broader reach to the ALS and MS community. Within the Exploitation activities, a series of Focus...

by Nicola Ferro, Full professor in computer science at the Department of Information Engineering of the University of Padua, Italy.   During its ideation but, even more, during its execution, the BRAINTEASER project adopted a strong focus on...

By: Sergio González Martínez, Universidad Politécnica de Madrid With the support of: Natalia Allegretti, ECHAlliance - The Global Health Connector   The BRAINTEASER project is at the forefront of healthcare advancements, utilising Artificial...

The BRAINTEASER Community of Practice Second webinar   Advances in digital technology are helping us to predict the onset of a disease, how it will progress, or which is the best treatment option for a particular person. In other words,...

The Lisbon Academic Medical Center (Centro Académico de Medicina de Lisboa-CAML) is one of the four clinical hubs within the BRAINTEASER initiative, with a specific focus on amyotrophic lateral sclerosis (ALS) patients. Currently, the center is...

At the Brain Innovation Days held in Brussels on October 26-27, 2023, organised by the European Brain Council, representatives from the BRAINTEASER project and from other pertinent initiatives gathered for a roundtable discussion. The focus was on...

By: Nicola Ferro, University of Padua, Italy   iDPP@CLEF [1] is an open evaluation challenge to assess the performance of Artificial Intelligence (AI) algorithms to predict the progression of Amyotrophic Lateral Sclerosis (ALS) and Multiple...

Participating in collaborative networks with pertinent projects and initiatives is pivotal for progressing in research and innovation pursuits. This collaborative approach offers numerous advantages that greatly enhance the success and impact of...

3rd On-line Workshop 11 December 2023, 14:00 – 15:30 CET   BRAINTEASER is a data science project that seeks to exploit the value of large clinical datasets, integrated with lifestyle and environmental data collected through low-cost sensors,...

The Digital Health Society Summit 2023 session “Refining the connections: Advancing evidence on the linkages between environment, health and data” dived into the relationships between the environment and human health, focusing on the role of data...

Mamede de Carvalho, a renowned neurologist and the head of the Amyotrophic Lateral Sclerosis (ALS) Clinic at Centro Hospitalar Universitário Lisboa Norte (CHULN), situated at the prestigious Hospital de Santa Maria, recently unveiled the exciting...

The EU ALS Coalition policy paper has been officially presented at the EU ALS Coalition event “Time to improve the life of people living with ALS | Policy recommendations for improved diagnosis, care, and treatment” on 7th September 2023. The paper...

As part of the BRAINTEASER activities with linked EU projects, a roundtable discussion will be held at 2023 Brain Innovation Days (BIDays). Every year, BIDays bring the brain ecosystem together to foster dialogue, exchange knowledge, accelerate...

Led by the European Brain Council, Brain Innovation Days is a two-day event packed with countless networking/matchmaking opportunities. Participants include neuroscientists but also healthcare professionals, people with brain disorders, start-ups,...

European Union-funded project BRAINTEASER has just announced the development of two tools–a dashboard and mobile application (app)–to help health professionals and patients with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). The...

You can register here to join the event online, but if you wish to join us in presence please click here! BRAINTEASER is a data science project that employs AI-based clinical software and mobile apps to support patients with amyotrophic lateral...

The second edition of the Brain Innovation Days took place on 11-12 October 2022 in Brussels (Belgium) and featured BRAINTEASER as one of the exhibitors in the Innovation Hall. This year's edition of the event – organised annually by BRAINTEASER...

The Digital Health Society Summit 4th edition, that took place virtually on October 4th and 5th 2022, has seen the contribution of BRAINTEASER in two relevant panel discussions: “How do you maximise the use of Health data for innovation...

On 6 October 2022, we recognise European Carers Day, a campaign led by Eurocarers. It aims to coordinate and foster national efforts to raise awareness of carers’ issues under a pan-European structure. Informal care represents the most significant...

Vladimir Urosevic, Research and Development Manager of Belit, represented the BRAINTEASER Consortium at the 12th IEEE International Conference on Consumer Technology ICCE-Berlin 2022 organized by the IEEE Consumer Technology Society. The Conference...

BRAINTEASER is excited to take part in the iDPP@CLEF Challenge 2022 happening on 5-8 September, We recently spoke about the event with organiser and full-time computer science professor Nicola Ferro at the University of Padua, Italy. Continue...

ECIR is the premier European conference on Information Retrieval and Information Access (CORE Rank A). ECIR teams up with CLEF in order to strengthen the European research community and organizes a session dedicated to presenting the ongoing labs...

Amyotrophic Lateral Sclerosis (ALS) is a chronic disease, characterized by progressive or alternate impairment of neurological functions (motor, sensory, visual, cognitive). Patients have to manage alternated periods in hospital with care at home,...

The first out of four BRAINTEASER Focus Groups dedicated to the project’s results exploitation and sustainability, was held on February 1st 2022. These exploitation Focus Groups aim to broaden the project’s vision on users and market needs,...

The inherent complexity of degenerative neurological diseases, such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), and the particular requirement for unravelling new biomarkers warrant a novel approach that integrates...

As part of its dissemination core set of activities, BRAINTEASER reached out to other EU funded Horizon2020 projects with similar objectives and common challenges with the aim to identify potential areas of collaboration. A first meeting took place...

One of the main objectives of the BRAINTEASER project is to exploit its results with the ultimate aim of improving care and quality of life of ALS and MS patients. To accompany the BRAINTEASER Consortium towards the most suitable results’...

The BRAINTEASER community of practice will focus on the clinical use of Artificial Intelligence and digital tools to manage ALS and MS disease. It will be an innovation community to create new breakthrough ideas, approaches, and knowledge. The...

On November 16th, the 17th Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2021) hosted the Special Session “Artificial Intelligence and Statistical Methods for Neurodegenerative Diseases”. The special...

The Intelligent Disease Progression Prediction (iDPP) challenge aims at designing and developing an evaluation infrastructure for AI algorithms able to: ●      better describe disease mechanisms; ●     ...

On the 24th of November 2021, The Digital Health Society (DHS) and the ECHAlliance hosted a panel session within the Digital Health Society Summit 2021, on “Cultural and regional aspects influencing digital health adoption and upscale”, involving...

The use of technologies in the treatment and management of multiple sclerosis: the experience of Pieter van Galen, Patient advocate, European Multiple Sclerosis Platform (EMSP) Pieter van Galen is from the Netherlands and studied Business &...

BRAINTEASER project aims to understand if different ecological factors can affect disease phenotype and progression of patients with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). Few studies investigated the spatial distribution...

BRAINTEASER project aims to understand if different ecological factors can affect disease phenotype and progression of patients with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). The “Amyotrophic Lateral Sclerosis” campaign wants...

BRAINTEASER project aims to support patients with amyotrophic lateral sclerosis and multiple sclerosis and their clinicians. “Amyotrophic Lateral Sclerosis” campaign wants to bring attention to this condition and analyse the variables that might...

BRAINTEASER project aims to support patients with amyotrophic lateral sclerosis and multiple sclerosis and their clinicians. "Get to Know more about Multiple Sclerosis" campaign wants to bring attention to this condition and on the variables that...

On 15-17 November 2021, the 17th Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2021) will take place online. In this context, the University of Padova (Padova, Italy), member of the BRAINTEASER...

On June 3rd took place the first open Co-design workshop of BRAINTEASER to present and discuss the digital tools that the consortium is in process of design and development. The workshop was conducted by Manuel Ottaviano (Universidad Politécnica of...

On the occasion of the World Multiple Sclerosis Day (30 May 2021), the European Brain Council (EBC), member of the BRAINTEASER Consortium, announced the release of its new policy paper, “RETHINKING MS in times of COVID-19”. This new paper is part...

The Environmental Sensor workshop - organized by both technical and clinical BRAINTEASER’ partners – was aimed at discussing some crucial aspects for the development of meaningful Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS)...

BRAINTEASER has started the co-design activities to define the system functionalities to be developed to improve the Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS)patients’ quality of life, and to support caregivers and health...

Officially started on the 1st of January 2020, the H2020 BRAINTEASER project kicked off its operational activities last week, January 28th and 29th, at the presence of its project officer Mr Tobias Wiesenthal, Head of Sector 'Research and...